Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Human papillomavirus (HPV) is a viral infection that, if does not go away, can cause health
problems like genital warts and cancer. The national immunization schedules for individuals …

Executive summary Globally, more than 1 million curable sexually transmitted infections
(STIs) occur each day. According to WHO global estimates for 2016, there were roughly 376 …

Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital
cancers. However, global HPV vaccine coverage falls short of global targets and has seen …

More than 90% of cervical cancer deaths occur in low-and middle-income countries (LMICs),
which have limited capacity to mount the comprehensive national screening and precancer …

Summary Background In May, 2018, the Director-General of WHO issued a global call to
eliminate cervical cancer as a public health problem, which will involve ambitious screening …

METHODS: Data were derived from the National Immunization Survey-Teen, spanning 2008–
2018. Using health care provider–verified vaccination histories, we examined trends in …

Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …

Background: Our understanding about knowledge, attitudes and perceptions (KAP) of
immigrants regarding human papillomavirus (HPV) vaccine is poor. We present the first …

Simple Summary Head and neck cancers of the oropharyngeal subsite can be driven by the
human papillomavirus (HPV). In countries such as the United States, the incidence of HPV …